Elucidata_logo_large print (1)


Innovation partner

At Elucidata, we have developed Polly, an industry-leading data-centric MLOps platform for life sciences. Polly's curation technology cleans and links 20 different types of biomedical data at scale into a format suitable for statistical and machine learning-based analyses. The platform provides partners in the life sciences industry with 70 TB of ML-ready biomedical data from 30 different public and premium sources. Polly  has enabled the identification and detection of multiple validated drug targets across immunology, oncology, and metabolomic disorders at Pfizer, Agios Pharmaceuticals, Genentech, Yale University and has 40+ research partners from premier biopharma companies and research labs.